Lyme disease is a multisystem
disease that can affect skin, nervous system, heart and joints.
Lyme arthritis can develope in about 60% of "not treated"
Lyme disease patients, 10% of patients may develope chronic arthritis.
Lyme arhritis symptoms (especially chronic arthritis) is similar to rheumatoid arthritis. The purpose of this study was to establish the usefulness of examinations of serum levels of matrix metalloproteinases MMP-3, MMP-9, tissue inhibitor of metalloproteinases 1 (TIMP-1), hialuronic acid (HA) and antibodies against cyclic citrullinated peptide (anti-CCP) in
Lyme arthritis, rheumatoid arthritis (RA) and patients with arthritic complaints. Plasma levels of MMP-3, HA and anti-CCP were significantly higher in RA group than in
Lyme arthritis group and patients with arthritic complaints. There were no significant differences in serum levels of MMP-3, MMP-9, TIMP-1, HA, anti-CCP between
Lyme arthritis patients and patients with arthritic complaints and these parameters are not usefull in differential diagnoses of